| Swords R, Mahalingam D, Padmanabhan S, et al.
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:89-101.
Abstract | Full Citation | Find Related Articles | | Fava C, Kantarjian H, Cortes J, et al.
Development and targeted use of nilotinib in chronic myeloid leukemia. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:233-243.
Abstract | Full Citation | Find Related Articles | | Huang X, Patel S, Ahmed N, et al.
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:215-219.
Abstract | Full Citation | Find Related Articles | | Campbell T, Felsten L, Moore J
Disappearance of lentigines in a patient receiving imatinib treatment for familial gastrointestinal stromal tumor syndrome. [Journal Article]
Arch Dermatol 2009 Nov; 145(11):1313-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yoshida C, Takeuchi M, Tsuchiyama J, et al.
Successful Treatment of KIT D816V-positive, Imatinib-resistant Systemic Mastocytosis with Interferon-alpha. [Journal Article]
Intern Med 2009; 48(22):1973-8.
Abstract | Full Citation | Find Related Articles | | Pantaleo MA, Nannini M, Battista MD, et al.
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. [JOURNAL ARTICLE]
Cancer Treat Rev 2009 Nov 13.
Abstract | Full Citation | Find Related Articles | | Pierotti MA, Negri T, Tamborini E, et al.
Targeted Therapies: The Rare Cancer Paradigm. [JOURNAL ARTICLE]
Mol Oncol 2009 Oct 28.
Abstract | Full Citation | Find Related Articles | | Ohtomo T, Miyazawa K, Naito M, et al.
Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation. [JOURNAL ARTICLE]
Biochem Biophys Res Commun 2009 Nov 10.
Abstract | Full Citation | Find Related Articles | | Ogbogu PU, Bochner BS, Butterfield JH, et al.
Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy. [JOURNAL ARTICLE]
J Allergy Clin Immunol 2009 Nov 10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Masiello D, Gorospe G, Yang AS
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. [JOURNAL ARTICLE]
J Hematol Oncol 2009 Nov 12; 2(1):46.
Abstract | Full Citation | Find Related Articles |    |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
